53865-18-2

Usage

InChI:InChI=1/C21H28O3/c1-4-5-6-7-14-11-18(23)20-16-10-15(13-22)8-9-17(16)21(2,3)24-19(20)12-14/h8,11-13,16-17,23H,4-7,9-10H2,1-3H3/t16-,17-/m1/s1

Upstream product

• 51263-83-3 (-)-9-nor-9-formyl-Δ⁸-tetrahydrocannabinol acetate 
• 23050-54-6 Δ⁶-Tetrahydro-cannabinylacetat 
• 7569-26-8 chloromethyl p-tolylsulfone 
• 6616-69-9 dl-6aα,7,10,10aα-Tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9(8H)-on 
• 83889-49-0 9-β-bromo-11-oxo-6a,10a-trans-HHC 
• 61597-37-3 4-(1-hydroxy-1-methylethyl)-1-methoxy-1,4-cyclohexadiene 
• 6616-69-9 11-nor-9-keto-6a,10a-cis-HHC 
• 500-66-3 Olivetol 

Downstream Products

• 25952-85-6 11-hydroxy-6a,10a-trans-Δ⁸-THC 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted and 11- or 12-substituted Δ8-tetrahydrocannabinol

The synthesis of a variety of novel 10-substituted cannabidiol (CBD) and 11- or 12-substituted Δ8-tetrahydrocannabinol (Δ8-THC) analogues containing amino, alkylamino, azido, or a N,N-bis(2-chloroethyl)amino functional group is descr

The synthesis of some 11-substituted tetrahydrocannabinol metabolites

9-Bromo-11-oxo-hexahydrocannabinol (5) was prepared from the ketocannabinoid 3b via the epoxysulfone 4.The dehydrobromination of the bromoaldehyde 5 could be controlled to give either the thermodinamically more stable Δ8-aldehyde 2c, or the Δ9-aldehyde 1c by an intramolecularly assisted elimination.Reduction of the unsaturated aldehydes gave the allylic alcohol metabolites 2a and 1a, respectively.